The p38 MAPK inhibitor SB202190 has been reported to impair the proliferation of human colon cancer cell lines in vitro and in mouse xenografts, which has been correlated with autophagy induction and increased expression of HER-3 and GABARAP [23, 25]. Here, ERBB3 is linked to malignant colon neoplasm.